Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignanciesTodd M Zimmerman, Helena Harlin, Olatoyosi M Odenike, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB AlterationsNoura J Choudhury, Alexa Campanile, Tatjana Antic, et al.
Cancer|December 24, 2003
A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinomaNicholas J Vogelzang, Theodore Karrison, Walter M Stadler, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2005
Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanineMelissa L Fishel, Michael P Gamcsik, Shannon M Delaney, et al.
European Journal of Cancer (Oxford, England : 1990)|July 25, 2008
A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumoursSamir D Undevia, Federico Innocenti, Jacqueline Ramirez, et al.
Investigational New Drugs|March 4, 2006
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinomaAmy C Peterson, Helena Harlin, Theodore Karrison, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2017
Randomized Controlled Ethanol Cookstove Intervention and Blood Pressure in Pregnant Nigerian WomenDonee Alexander, Amanda Northcross, Nathaniel Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2009
Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatmentMichael L Maitland, Kristen E Kasza, Theodore Karrison, et al.
Pageof 15